Seattle, WA -- (SBWIRE) -- 11/14/2019 -- Gunshot injury is also known as ballistic trauma, it is caused by a bullet, knife or any sharp projectile that is shot into the body. Such injuries can lead to excessive bleeding, tissue and organ damage, paralysis or broken bones, and some time may also lead to death. The immediate effect of a gunshot wound is severe bleeding, which depends on the location of the injury, and the type and speed of the penetrated bullet. The gunshot injuries treatment helps in stopping bleeding within seconds, thereby saving the life of an injured person.

Request Sample Report At: https://www.coherentmarketinsights.com/insight/request-sample/772

The goal of these products is to efficiently treat severe cases by increasing the rate of the blood clotting process
The global gunshot injuries treatment market was valued at US$ 8.0 million in 2017 and is expected to witness a CAGR of 8.2% over the forecast period (2017 – 2025).

Rising incidence of traumatic injury is projected to propel the growth of the gunshot injuries treatment market

The rising number of Traumatic injury is a major factor fueling the market growth of gunshot injuries. According to the Centers for Disease Control and Prevention, around 84,000 gun-shot related injuries and around 2 million knife-related injuries were recorded in 2013, globally. The injuries cause deep hemorrhagic wounds, which are characterized by profuse bleeding from the ruptured blood vessels. Stats released by the Food and Drug Administration,2015, has predicted that the deaths due to a gunshot or traumatic injuries are expected to account for 30-40% of civilian deaths, often before the patient reaches the hospital. It further revealed that the innovative FDA approved Xstat would possibly make a difference to prevent mortality, if made available to the emergency personnel to prevent delay in care, as hospital care cannot be accessed immediately. North America is projected to hold a dominant position in the gunshot injuries treatment market, and this can be attributed to the availability of advanced and FDA approved products such as sponge-filled syringe and bandages. According to data published in Trauma Reports in 2012, penetrating trauma is the second major cause of injury-related deaths, with an around 60,000 - 80,000 occurrence rate of a nonfatal gunshot, in the U.S.

Increasing FDA approval of the gunshot injuries treatment products is the prime factor fueling the market growth

Advancements in medicine and technology help to prevent the mortality rate associated with gunshot injuries, hence this is expected to fuel the demand for gunshot injury product. Xstat is the only gunshot wound management device, which is extensively used on battlefields, globally. XStat was manufactured by RevMedx and approved by the FDA in April 2014, to plug up life-threatening wounds. Furthermore, the launch and availability of these devices are projected to propel the market in the Asia Pacific and Europe. The clearance of the Xstat 30 for gunshot injury treatment expands the device's indication for use for adults and adolescents in the general population, thereby facilitating the market growth. XStat 30 was FDA-approved in December 2015, for use for patients with high life-threatening risk, suffering from immediate and severe hemorrhagic shocks when definitive care at an emergency care facility cannot be achieved within minutes.

For More Details On this Report: https://www.coherentmarketinsights.com/market-insight/gunshot-injuries-treatment-market-772

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.